) (“the company”) earned a net profit of Baht 3,359 million, slightly increased by Baht 184 million or 6% from 2017. The increase was due to... https://market.sec.or.th/public/idisc/Download?FILEID=dat/news

making a forward exchange contact. The Company can maintain the level of selling and administrative expenses. Including, financial costs in the same criteria. The Company therefore earned net profit in Q2

(29) Net Profit 52 50 4 140 104 35 Total Revenues In the three-month period ended 30 September 2019 and 2018, total revenues of the Company were Baht 538 million and Baht 457 million, respectively

months ended 31st December 2019 of the Company and its subsidiaries as details below: (Unit: Baht millions) 1. Operating Performance For the period of three months ended 31st Dec 2019, the net profit for

decrease in Gross Profit Margin was from appreciation of Baht against other currencies causing lower revenue and gross profit although the company raised sales volume. For the three-month period ended 31

earnings continue to grow which is the highest quarterly profit statistics. The net profit report 226.9 million Baht in Q2/2020. The company had the same amount of collection in the first half of the year

medical supply manufacturing and distribution, which increased from the same period of the previous year for 4.80 million baht or 18.99%, resulting in the increase of the Company Group’s gross profit for

510 - 940 Million through the concession agreement period. Overview Operational Results In the first quarter of the year 2018, the Company had the net profit attributable to equity holders of the

export sector has expanded well from the economic recovery of trade relevant countries. Beside, company and its subsidiaries recorded the profit sharing to non-controlling interest in a subsidiary by Baht

, following the gradual economic growth and the export sector has expanded well from the economic recovery. Beside, company and its subsidiaries recorded the profit sharing to non-controlling interest in a